SEC Company Response from Catheter Precision, Inc. (VTAK) (CIK 0001716621) (VJET) — Sep 24, 2018
Catheter Precision, Inc. (VTAK) (CIK 0001716621)
Date: Sept. 24, 2018 · CIK: 0001716621 · Accession: 0001193125-18-281340
AI Filing Summary & Sentiment
File numbers found in text: 333-226191
Letter
Company Acceleration Request
September 24, 2018
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 3030
Washington, DC 20549-3720
Attention: Amanda Ravitz
Heather Percival
Caleb French
Eric Atallah
Kevin Kuhar
Re: Ra Medical Systems, Inc.
Registration Statement on Form S-1
File No. 333-226191
Acceleration Request
Requested Date: September 26, 2018
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, and Rule 12d1-2 of the Securities Exchange Act of 1934, as amended, Ra Medical Systems, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-226191) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Martin J. Waters at (858) 350-2308.
* * * *
Sincerely,
Ra Medical Systems, Inc.
Show Raw Text
CORRESP 1 filename1.htm Company Acceleration Request September 24, 2018 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Mail Stop 3030 Washington, DC 20549-3720 Attention: Amanda Ravitz Heather Percival Caleb French Eric Atallah Kevin Kuhar Re: Ra Medical Systems, Inc. Registration Statement on Form S-1 File No. 333-226191 Acceleration Request Requested Date: September 26, 2018 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, and Rule 12d1-2 of the Securities Exchange Act of 1934, as amended, Ra Medical Systems, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-226191) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Martin J. Waters at (858) 350-2308. * * * * Sincerely, Ra Medical Systems, Inc. /s/ Dean Irwin Dean Irwin Chief Executive Officer cc: Andrew Jackson, Ra Medical Systems, Inc. Martin J. Waters, Wilson Sonsini Goodrich & Rosati, P.C. Zachary B. Myers, Wilson Sonsini Goodrich & Rosati, P.C. Joshua A. Kaufman, Cooley LLP Donald Shum, Cooley LLP Bruce Rucks, Deloitte & Touche LLP